中文 | English
Return
Total: 177 , 1/18
Show Home Prev Next End page: GO
Author:(Lingyan WANG)

1.Recent advances of aberrant expression of nucleophosmin in acute leukemia

Lingyan WANG

Journal of Leukemia & Lymphoma 2014;23(12):754-757

2.Schnitzler syndrome

Lingyan WANG ; Jie KUANG

Chinese Journal of Dermatology 2013;46(11):792-794

3.Discontinuation of tyrosine kinase inhibitor therapy: can chronic myeloid leukemia be cured?

Lingyan WANG ; Jianda HU

Journal of Leukemia & Lymphoma 2012;21(3):129-132

4.Dendrite morphological characteristics during degenerative process of retinal ganglion cells in royal college surgeons rats

Lingyan WANG ; Yi WANG ; Zhenqin YING

Journal of Third Military Medical University 2003;0(10):-

5.Distribution and antibiotic resistance profile of nonfermentative gram negative bacteria

Lingyan WANG ; Guangfa ZHU ; Aiping WANG

Chinese Journal of Infection and Chemotherapy 2014;(4):305-309

6.Teaching Reform of Rehabilitation Assessment in Higher Vocational Education Rehabilitation Treatment Technology

Liyan WANG ; Xiaochen WANG ; Lingyan LI

Chinese Journal of Rehabilitation Theory and Practice 2011;17(6):596-597

7.Advances in the research of pharmacogenomics of cyclophosphamide.

Lingyan CHEN ; Xueding WANG ; Min HUANG

Acta Pharmaceutica Sinica 2014;49(7):971-6

8.Current situation of off-label drug use in China and abroad and its inspirations

Lingyan JIAN ; Xiaojing HE ; Shan WANG

Chinese Journal of Hospital Administration 2015;31(1):46-49

9.Research on Auditory Steady-state Responses to Multiple Simultaneous Stimuli of Normal-hearing Adults

Lingyan MO ; Demin HAN ; Qi WANG

Journal of Audiology and Speech Pathology 2004;0(06):-

10.Combined use of RT-PCR and gel electrophoresis to detect expression of transforming growth factor beta1 in mouse lung fibroblasts in vitro

Weitao YU ; Dongjian WANG ; Lingyan AI

Chinese Journal of Tissue Engineering Research 2017;21(8):1268-1272

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 177 , 1/18 Show Home Prev Next End page: GO